Cogent Biosciences-on Track to Complete Enrollment in Registration-Directed Summit Part 2 Study in Q2 of 2025, Report Topline Results by Year-End 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.